A detailed history of Towerpoint Wealth, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Towerpoint Wealth, LLC holds 6,945 shares of ABT stock, worth $815,065. This represents 0.38% of its overall portfolio holdings.

Number of Shares
6,945
Previous 7,399 6.14%
Holding current value
$815,065
Previous $768,000 2.99%
% of portfolio
0.38%
Previous 0.39%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$100.07 - $118.13 $45,431 - $53,631
-454 Reduced 6.14%
6,945 $791,000
Q2 2024

Jul 12, 2024

BUY
$100.73 - $112.44 $26,693 - $29,796
265 Added 3.71%
7,399 $768,000
Q1 2024

Apr 15, 2024

BUY
$109.52 - $120.96 $175,670 - $194,019
1,604 Added 29.01%
7,134 $810,000
Q4 2023

Jan 23, 2024

SELL
$90.19 - $110.4 $1,984 - $2,428
-22 Reduced 0.4%
5,530 $608,000
Q3 2023

Oct 10, 2023

BUY
$95.53 - $114.62 $3,534 - $4,240
37 Added 0.67%
5,552 $537,000
Q2 2023

Jul 20, 2023

BUY
$100.78 - $112.29 $10,581 - $11,790
105 Added 1.94%
5,515 $601,000
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $34,094 - $40,131
352 Added 6.96%
5,410 $547,000
Q4 2022

Feb 10, 2023

SELL
$95.06 - $111.52 $5,608 - $6,579
-59 Reduced 1.15%
5,058 $555,000
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $3,289 - $3,809
-34 Reduced 0.66%
5,117 $495,000
Q2 2022

Aug 08, 2022

BUY
$102.07 - $123.37 $6,124 - $7,402
60 Added 1.18%
5,151 $560,000
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $6,499 - $7,925
57 Added 1.13%
5,091 $603,000
Q4 2021

Feb 04, 2022

SELL
$115.53 - $141.46 $5,198 - $6,365
-45 Reduced 0.89%
5,034 $708,000
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $33,014 - $36,523
283 Added 5.9%
5,079 $600,000
Q2 2021

Jul 27, 2021

SELL
$105.79 - $124.53 $24,543 - $28,890
-232 Reduced 4.61%
4,796 $556,000
Q1 2021

May 10, 2021

BUY
$108.84 - $128.23 $547,247 - $644,740
5,028 New
5,028 $603,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Towerpoint Wealth, LLC Portfolio

Follow Towerpoint Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Towerpoint Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Towerpoint Wealth, LLC with notifications on news.